Altium har dragit igång

Den kroatiska organisationen Croatian Association for Cancer Research (CACR) har samlat landets grädda inom cancerforskning för ett 2 dagars seminarium fyllt med information om de senaste rönen och presentation av teknik som stödjer forskningen. CACR ingår i den större europeiska organisationen European Association for Cancer Research (EACR) och möjliggör för forskare att genomföra gemensamma forskningsprojekt utanför sitt resp lands gränser.  

Ur den 64 sidiga programförklaringen ser vi att EACR medfinansierar detta seminarie tillsammans med sponsorer där Altium ingår. 

ORAL PRESENTATIONS

Bland talarna hittas Altiums Ines Topalović Piteša som presenterade HoloMonitor. 

Non-Invasive and Label-Free Live Cell Imaging, Weighing and Sorting in 3D and More! 

 [Sponsored by Altium International] 

Ines Topalović Piteša 
Altium International, Zagreb, Croatia (e-mail: ines.topalovic@alphachrom.hr) 

Quantitative Phase Imaging (QPI) is a transformative, non-invasive imaging technology that has become essential for live cell analysis in cancer research. 

QPI operates by detecting the subtle phase shifts in light as it traverses live cells, creating high-resolution, quantitative images and data without the need for labels or dyes that may alter cell behavior. This approach allows for continuous, real-time monitoring of cells, capturing critical insights into cancer cell biology, including proliferation rates, morphological changes, motility, and migratory patterns—factors fundamental to understanding tumor progression and metastasis. 

In the context of drug development, QPI proves invaluable by enabling researchers to observe the real-time effects of new therapeutics on cancer cells in a label-free environment, preserving cell integrity for accurate assessments of cell viability and response to treatment. 

The HoloMonitor® system, developed by Phase Holographic Imaging, embodies this technology by integrating seamlessly into standard incubators and offering a user-friendly platform for prolonged, high-content cell analysis. 

This lecture will highlight the unique advantages of QPI and HoloMonitor® in cancer research, illustrating how non-destructive, real-time cellular monitoring is advancing our understanding of cancer dynamics and supporting the development of targeted therapies. 

Attendees will gain insight into the versatility of QPI as a tool for live cell studies and explore its expanding role in facilitating breakthrough discoveries in oncology and therapeutic innovation.

Min kommentar
Detta bör vara första gången en representant från Altium självständigt håller i en presentation av HoloMonitor inför en större publik bestående av vassa forskare,i detta fallet cancerforskare.

De massiva utbildningsinsatser PHI`s anställda genomfört hos Altiums alla dotterbolag börjar nu bära frukt. Altium har dragit igång!

                                            Mvh the99